GLOBEALERT
BUSINESS● LOWAug 7 · Aug 7, 2026, 11:32 AM

Gyre Therapeutics GAAP EPS of -$0.12 misses by $0.06, revenue of $29.1M beats by $2.61M

Seeking Alpha Tech

Gyre Therapeutics reported GAAP EPS that missed expectations but revenue that beat estimates. This shows a mixed financial performance for the company.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Business